Cardiovascular Risk Assessment Model in Patients With MI
NCT ID: NCT03957005
Last Updated: 2019-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2018-11-06
2023-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Causes of Delayed Presentation of MI Patients to a Tertiary Care Hospital
NCT07160556
The Prognosis of Acute Myocardial Infarction
NCT02737956
Quality of Life in Patients With Chronic Ischemic Heart Disease
NCT00005671
Biomarkers in Acute Cardiac Care
NCT02355457
Social Support and Myocardial Ischemia
NCT00005449
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The predictors recorded in this study are categorized in three main issues: 1) lifestyle, including: nutritional status, physical activity, tobacco smoking and drug abuse, sleep quality, and sexual function assessed by relevant questionnaires. 2) behavioral and psychological factors, including: depression, psychological distress, health anxiety, health related quality of life, type D personality, coping strategies, sense of coherence and medication adherence also measured by appropriate questionnaires. 3) Traditional risk factors, including: hypertension, diabetes, and hyperlipidemia which will be extracted from medical and laboratory records of patients and questionnaires. All predictor variables will be assessed in every year follow-up for three years during the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* providing written informed consent
Exclusion Criteria
* living in a nursing home or other institutions
* having a serious medical condition with a survival of less than 3 years
* participation in another scientific study
* not willing to participate in each phase of the study.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute for Medical Research Development
UNKNOWN
Isfahan University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Masoumeh Sadeghi
Head of Cardiac Rehabilitation Research Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Masoumeh Sadeghi, MD
Role: PRINCIPAL_INVESTIGATOR
Cardiac Rehabilitation Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dr Heshmat Hospital
Rasht, Gilan Province, Iran
Shahid Mohammadi hospital
Bandar Abbas, Hormozgan, Iran
Chamran Cardiology Hospital
Isfahan, , Iran
Shahid Rajaei hospital
Tehran, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
964708
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.